3 Biotechs That Have Doubled Investors' Money in Less Than a Year Post author:Sam Post published:January 22, 2018 Post category:BioPharma Having a stock double in value is a good thing. Source: BioSpace You Might Also Like Boehringer CFO Quits After 16 Months on the Job Over Differences in Strategy December 14, 2017 Biotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene July 5, 2017 Amgen Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects May 21, 2017
